What do systematic reviews say?

Intravenous vs oral cyclophosphamide

Intravenous may leads to lower adverse events: all infections compared with oral cyclophosphamide (low certainty).

• Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children 2020 · Cochrane Headline outcomes only
  RR 0.14 [0.03, 0.72]
  2 studies · 83 participants
  Low